Amyloidosis Support Groups Inc
Amyloidosis Support Groups Inc shows strong program spending and no executive compensation amidst consistent asset growth.
EIN: 202909816 · Wood Dale, IL · NTEE: H90 · Updated: 2026-03-28
| Metric | Value |
|---|---|
| Total Revenue | $500K |
| Total Expenses | $454K |
| Program Spending | 75% |
| CEO/Top Officer Pay | $1 |
| Net Assets | $878K |
| Transparency Score | 90/100 |
Is Amyloidosis Support Groups Inc Legit?
Some Concerns
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
Amyloidosis Support Groups Inc directs 75% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.
About Amyloidosis Support Groups Inc
Amyloidosis Support Groups Inc (EIN: 202909816) is a nonprofit organization based in Wood Dale, IL, classified under NTEE code H90. The organization reported total revenue of $500K and total assets of $1.2M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Amyloidosis Support Groups Inc's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Amyloidosis Support Groups Inc is a small nonprofit that has been operating for 21 years, with 13 years of IRS 990 filings on record (2012–2024). Revenue has grown at a compound annual rate of 14.1%.
Key Financial Metrics (2024)
From the most recent IRS 990 filing on record:
| Total Revenue | $430K |
| Total Expenses | $454K |
| Surplus / Deficit | $-24,207 |
| Total Assets | $885K |
| Total Liabilities | $6K |
| Net Assets | $878K |
| Operating Margin | -5.6% |
| Debt-to-Asset Ratio | 0.7% |
| Months of Reserves | 23.4 months |
Financial Health Grade: B
In 2024, Amyloidosis Support Groups Inc reported a deficit of $24K with expenses exceeding revenue, holds 23.4 months of operating reserves (strong position), has a debt-to-asset ratio of 0.7% (very low leverage).
Financial Trends
Over 13 years of filings (2012–2024), Amyloidosis Support Groups Inc's revenue has grown at a compound annual growth rate (CAGR) of 14.1%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2024 | +58.2% | +246.5% | -2.2% |
| 2023 | +109.0% | +19.2% | +18.6% |
| 2022 | +20.5% | +69.3% | +2.7% |
| 2021 | -80.2% | -83.9% | +5.7% |
| 2020 | +32.9% | +110.2% | +24.3% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 2000 |
| IRS Ruling Date | 2005 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Amyloidosis Support Groups Inc with a Mission Score of 90 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 15%
- programs: 75%
- fundraising: 10%
According to IRS 990 filings, Amyloidosis Support Groups Inc allocates its expenses as follows: admin: 15%, programs: 75%, fundraising: 10%. With 75% directed toward programs, this reflects a strong commitment to its charitable mission.
Key Financial Metrics (2024)
From the most recent IRS 990 filing on record:
- The organization reported a deficit of $24K, with expenses exceeding revenue.
- Debt-to-asset ratio: 0.7%.
Executive Compensation Analysis
Executive compensation is reported as 0% across all available filing periods, indicating that officers and key employees do not receive salaries from the organization, which is highly commendable for an organization of its size with assets exceeding $1 million.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Red Flags
The following concerns were identified during AI analysis of Amyloidosis Support Groups Inc's IRS 990 filings:
- Small deficit in 202405 period (expenses $453,753 vs revenue $429,546), though minor in context of overall financial health.
Strengths
The following positive indicators were identified for Amyloidosis Support Groups Inc:
- Strong program spending ratio (75%)
- 0% officer compensation across all reported periods
- Consistent and significant growth in assets over the past decade
- Consistent revenue growth over the long term
- Low liabilities, indicating strong financial health and minimal debt
Frequently Asked Questions about Amyloidosis Support Groups Inc
Is Amyloidosis Support Groups Inc a legitimate charity?
Amyloidosis Support Groups Inc (EIN: 202909816) is a registered tax-exempt nonprofit based in Illinois. Our AI analysis gives it a Mission Score of 90/100. It has 13 years of IRS 990 filings on record. Total revenue: $500K. 1 red flag identified. 5 strengths noted. Financial health grade: B.
How does Amyloidosis Support Groups Inc spend its money?
Amyloidosis Support Groups Inc directs 75% of its spending to programs and services. Fundraising costs 10%. This exceeds the 65% industry benchmark.
Are donations to Amyloidosis Support Groups Inc tax-deductible?
Amyloidosis Support Groups Inc is registered as a tax-exempt nonprofit (EIN: 202909816). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
How much does the Amyloidosis Support Groups Inc CEO make?
Amyloidosis Support Groups Inc's highest-compensated officer earns $1 annually. The organization reported $500K in total revenue. Executive compensation data is disclosed in IRS 990 filings.
What percentage of Amyloidosis Support Groups Inc's spending goes to programs?
Amyloidosis Support Groups Inc directs 75% to programs, 10% to fundraising. This exceeds the 65% industry benchmark for efficient nonprofits.
How does Amyloidosis Support Groups Inc compare to similar nonprofits?
With a transparency score of 90/100 (Excellent), Amyloidosis Support Groups Inc is above average for NTEE category H90 nonprofits. The score reflects financial transparency, program spending efficiency, and governance quality based on IRS 990 data.
Where is Amyloidosis Support Groups Inc located?
Amyloidosis Support Groups Inc is headquartered in Wood Dale, Illinois and files with the IRS under EIN 202909816. It is classified under NTEE code H90.
How many years of IRS 990 filings does Amyloidosis Support Groups Inc have?
Amyloidosis Support Groups Inc has 13 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $500K in total revenue.
Is Amyloidosis Support Groups Inc a good charity?
Based on the financial data, Amyloidosis Support Groups Inc appears to be a very good charity. It dedicates a high percentage of its spending to programs (75%), has no executive compensation, and has consistently grown its assets and revenue over time, demonstrating financial stability and a strong commitment to its mission.
How has the organization's revenue grown over time?
The organization has shown significant revenue growth, increasing from $136,361 in 201605 to $429,546 in 202405, with a peak of $545,856 in 202005. This indicates a strong ability to attract funding.
What is the trend in the organization's assets?
Amyloidosis Support Groups Inc has consistently increased its assets, growing from $203,318 in 201605 to $884,795 in 202405, and currently holds $1,165,178. This demonstrates strong financial management and accumulation of reserves.
Does the organization have any liabilities?
The organization generally maintains very low liabilities. For instance, in 202405, liabilities were $6,367, and in several earlier periods (201705, 201805), liabilities were reported as $0. This indicates a healthy balance sheet with minimal debt.
Filing History
IRS 990 filing history for Amyloidosis Support Groups Inc showing financial trends over 13 years of public records:
Over 13 years of IRS 990 filings (2012–2024), Amyloidosis Support Groups Inc's revenue has grown by 385.1%, moving from $89K to $430K. Total assets increased by 1010.3% over the same period, from $80K to $885K. Total functional expenses rose by 352.7%, from $100K to $454K. In its most recent filing year (2024), Amyloidosis Support Groups Inc reported a deficit of $24K, with expenses exceeding revenue. The organization holds $6K in liabilities against $885K in assets (debt-to-asset ratio: 0.7%), resulting in net assets of $878K.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2024 | $430K | $454K | $885K | $6K | — | — |
| 2023 | $271K | $131K | $904K | $2K | — | View 990 |
| 2022 | $130K | $110K | $763K | $444 | — | View 990 |
| 2021 | $108K | $65K | $743K | $551 | — | View 990 |
| 2020 | $546K | $403K | $702K | $3K | — | View 990 |
| 2019 | $411K | $192K | $565K | $8K | — | View 990 |
| 2018 | $380K | $329K | $341K | $0 | — | View 990 |
| 2017 | $224K | $137K | $290K | $0 | — | View 990 |
| 2016 | $136K | $177K | $203K | $0 | — | View 990 |
| 2015 | $273K | $128K | $244K | $0 | — | View 990 |
| 2014 | $139K | $156K | $99K | $0 | — | View 990 |
| 2013 | $114K | $78K | $116K | $0 | — | View 990 |
| 2012 | $89K | $100K | $80K | $0 | — | View 990 |
Year-by-Year Financial Summary
- 2024: Revenue of $430K, expenses of $454K, and assets of $885K (revenue +58.2% year-over-year).
- 2023: Revenue of $271K, expenses of $131K, and assets of $904K (revenue +109.0% year-over-year).
- 2022: Revenue of $130K, expenses of $110K, and assets of $763K (revenue +20.5% year-over-year).
- 2021: Revenue of $108K, expenses of $65K, and assets of $743K (revenue -80.2% year-over-year).
- 2020: Revenue of $546K, expenses of $403K, and assets of $702K (revenue +32.9% year-over-year).
- 2019: Revenue of $411K, expenses of $192K, and assets of $565K (revenue +8.1% year-over-year).
- 2018: Revenue of $380K, expenses of $329K, and assets of $341K (revenue +69.8% year-over-year).
- 2017: Revenue of $224K, expenses of $137K, and assets of $290K (revenue +64.2% year-over-year).
- 2016: Revenue of $136K, expenses of $177K, and assets of $203K (revenue -50.0% year-over-year).
- 2015: Revenue of $273K, expenses of $128K, and assets of $244K (revenue +95.6% year-over-year).
- 2014: Revenue of $139K, expenses of $156K, and assets of $99K (revenue +22.4% year-over-year).
- 2013: Revenue of $114K, expenses of $78K, and assets of $116K (revenue +28.6% year-over-year).
- 2012: Revenue of $89K, expenses of $100K, and assets of $80K.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for Amyloidosis Support Groups Inc:
Data Sources and Methodology
This transparency report for Amyloidosis Support Groups Inc is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.